Author:
Krumkamp Ralf,Struck Nicole Sunaina,Lorenz Eva,Zimmermann Marlow,Boahen Kennedy Gyau,Sarpong Nimako,Owusu-Dabo Ellis,Pak Gi Deok,Jeon Hyon Jin,Marks Florian,Jacobs Thomas,May Jürgen,Eibach Daniel
Abstract
AbstractA better understanding of disease-specific biomarker profiles during acute infections could guide the development of innovative diagnostic methods to differentiate between malaria and alternative causes of fever. We investigated autoantibody (AAb) profiles in febrile children (≤ 5 years) admitted to a hospital in rural Ghana. Serum samples from 30 children with a bacterial bloodstream infection and 35 children with Plasmodium falciparum malaria were analyzed using protein microarrays (Protoplex Immune Response Assay, ThermoFisher). A variable selection algorithm was applied to identify the smallest set of AAbs showing the best performance to classify malaria and bacteremia patients. The selection procedure identified 8 AAbs of which IFNGR2 and FBXW5 were selected in repeated model run. The classification error was 22%, which was mainly due to non-Typhi Salmonella (NTS) diagnoses being misclassified as malaria. Likewise, a cluster analysis grouped patients with NTS and malaria together, but separated malaria from non-NTS infections. Both current and recent malaria are a risk factor for NTS, therefore, a better understanding about the function of AAb in disease-specific immune responses is required in order to support their application for diagnostic purposes.
Funder
Deutsches Zentrum für Infektionsforschung
Bill and Melinda Gates Foundation
Projekt DEAL
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Mathison, B. A. & Pritt, B. S. Update on malaria diagnostics and test utilization. J. Clin. Microbiol. 55, 2009–2017 (2017).
2. Hogan, B. et al. Malaria coinfections in febrile pediatric inpatients: a hospital-based study from Ghana. Clin. Infect. Dis. 66, 10 (2018).
3. D’Acremont, V. et al. Beyond malaria: causes of fever in outpatient Tanzanian children. N. Engl. J. Med. 370, 809–817 (2014).
4. WHO. Guidelines for the Treatment of Malaria 3rd edn. (WHO, Geneva, 2015).
5. Donati, D. et al. Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect. Immun. 72, 5412–5418 (2004).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献